BRPI0507985A - derivados de piperazina uréia para o tratamento de endometriose - Google Patents

derivados de piperazina uréia para o tratamento de endometriose

Info

Publication number
BRPI0507985A
BRPI0507985A BRPI0507985-3A BRPI0507985A BRPI0507985A BR PI0507985 A BRPI0507985 A BR PI0507985A BR PI0507985 A BRPI0507985 A BR PI0507985A BR PI0507985 A BRPI0507985 A BR PI0507985A
Authority
BR
Brazil
Prior art keywords
treatment
endometriosis
urea derivatives
piperazine urea
piperazine
Prior art date
Application number
BRPI0507985-3A
Other languages
English (en)
Inventor
Richard Horuk
Ulrike Kaufmann
Original Assignee
Schering Aktiengellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Aktiengellschaft filed Critical Schering Aktiengellschaft
Publication of BRPI0507985A publication Critical patent/BRPI0507985A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

DERIVADOS DE PIPERAZINA URéIA PARA O TRATAMENTO DE ENDOMETRIOSE. para a produção de um medicamento para o tratamento de endometriose no ser humano, onde o tratamento compreende administrar a uma mulher com necessidade tal tratamento uma quantidade terapeuticamente eficaz do referido composto.
BRPI0507985-3A 2004-02-24 2005-02-23 derivados de piperazina uréia para o tratamento de endometriose BRPI0507985A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04090065 2004-02-24
PCT/EP2005/002036 WO2005079769A2 (en) 2004-02-24 2005-02-23 Piperazine derivatives for the treatment of endometriosis

Publications (1)

Publication Number Publication Date
BRPI0507985A true BRPI0507985A (pt) 2007-05-08

Family

ID=34878280

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0507985-3A BRPI0507985A (pt) 2004-02-24 2005-02-23 derivados de piperazina uréia para o tratamento de endometriose

Country Status (21)

Country Link
US (1) US20080119471A1 (pt)
EP (1) EP1727526A2 (pt)
JP (1) JP2007523126A (pt)
KR (1) KR20070033961A (pt)
CN (1) CN101090723A (pt)
AR (1) AR048068A1 (pt)
AU (1) AU2005215156A1 (pt)
BR (1) BRPI0507985A (pt)
CA (1) CA2556423A1 (pt)
CR (1) CR8584A (pt)
EA (1) EA200601514A1 (pt)
EC (1) ECSP066836A (pt)
GT (1) GT200500032A (pt)
IL (1) IL177406A0 (pt)
NO (1) NO20064298L (pt)
PA (1) PA8624501A1 (pt)
PE (1) PE20051129A1 (pt)
SV (1) SV2006002017A (pt)
TW (1) TW200539882A (pt)
WO (1) WO2005079769A2 (pt)
ZA (1) ZA200607970B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2007001829A1 (es) * 2006-06-23 2008-01-25 Smithkline Beecham Corp P-toluensulfonato de n-[4-cloro-2-hidroxi-3-(piperazina-1-sulfonil)fenil]-n-(2-cloro-3-fluorofenil)urea;procedimiento de preparacion;composicion farmaceutica;combinacion farmaceutica;y uso en el tratamiento de una enfermedad mediada por la quiimioquina il-8, tales como asma y epoc.
US8445674B2 (en) * 2009-10-21 2013-05-21 Hoffmann-La Roche Inc Heterocyclyl compounds
HUE040420T2 (hu) 2010-03-11 2019-03-28 Univ New York Amidvegyületek, mint RORyT modulátorok és felhasználásuk
PL3022202T3 (pl) 2013-07-18 2019-10-31 Novartis Ag Inhibitory autotaksyny zawierające heteroaromatyczny rdzeń pierścienia benzylowego - cyklicznego amidu

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207665B1 (en) * 1997-06-12 2001-03-27 Schering Aktiengesellschaft Piperazine derivatives and their use as anti-inflammatory agents
CA2489560A1 (en) * 2002-06-27 2004-01-08 Schering Aktiengesellschaft Substituted quinoline ccr5 receptor antagonists

Also Published As

Publication number Publication date
EA200601514A1 (ru) 2007-02-27
ECSP066836A (es) 2006-11-24
SV2006002017A (es) 2006-05-09
NO20064298L (no) 2006-11-24
CA2556423A1 (en) 2005-09-01
WO2005079769A3 (en) 2007-01-04
GT200500032A (es) 2005-10-31
US20080119471A1 (en) 2008-05-22
JP2007523126A (ja) 2007-08-16
ZA200607970B (en) 2008-12-31
CR8584A (es) 2007-08-28
AR048068A1 (es) 2006-03-29
PA8624501A1 (es) 2006-07-03
TW200539882A (en) 2005-12-16
AU2005215156A1 (en) 2005-09-01
PE20051129A1 (es) 2006-02-16
IL177406A0 (en) 2006-12-10
KR20070033961A (ko) 2007-03-27
EP1727526A2 (en) 2006-12-06
CN101090723A (zh) 2007-12-19
WO2005079769A2 (en) 2005-09-01

Similar Documents

Publication Publication Date Title
BR0312573A (pt) Derivados de fenil-[4-(3-fenil-1h-pirazol-4-il)-pirimidin-2-il]-amina
GEP20125691B (en) Compounds and compositions as protein kinase inhibitors
EA200700096A1 (ru) Производные 2-карбамид-4-фенилтиазола, способ их получения и их применение в терапии
SE0401342D0 (sv) Therapeutic compounds
MX2009011997A (es) Derivados de pirrolopirimidin-7-ona y su uso como farmaceuticos.
ATE452129T1 (de) N-phenyl-2-pyrimidine-amine derivatives
NO20085217L (no) Effektive pyrimidinderivater i behandlingen av kreft
UY30819A1 (es) Derivados de pirazol, composiciones farmacéuticas conteniéndolos, procesos de preparacion y aplicaciones
EA201000643A1 (ru) Замещенное производное этилендиамина для лечения микобактериальных заболеваний и фармацевтическая композиция на его основе
TW200716628A (en) Novel compounds
ECSP067076A (es) Derivados de pirimidina urea como inhibidores de la quinasa
BRPI0514736A (pt) inibidores do receptor sigma
EA201071038A1 (ru) Производные 1-бензил-3-гидроксиметилиндазола и их применение для лечения заболеваний, основанных на экспрессии mcp-1, cx3cr1 и p40
EA200800302A1 (ru) Применение производных и аналогов тиазола при лечении рака
MX2010009625A (es) Derivados de 1-bencil-3-hidroximetilindazol y uso de los mismos en el tratamiento de enfermedades basadas en la expresion de mcp-1, cx3cr1 y p40.
BR0209645A (pt) Oxazolo- e furopirimidinas e seu uso como medicamentos
WO2006108682A3 (en) Substances and pharmaceutical compositions for the inhibition of glyoxalases and their use as anti-fungal agents
UY29358A1 (es) Tiazolidinonas, su preparacion y su uso como medicamento
UY27772A1 (es) Inhibidores triariloxiariloxipirimidin-2,4,6- triona de metaloproteinasa.
CR10410A (es) Carboxamidas sustituidas.
TW200609222A (en) Diazole derivatives
BRPI0507985A (pt) derivados de piperazina uréia para o tratamento de endometriose
EA200870223A1 (ru) Производные бензоизоиндола для лечения боли
ECSP045405A (es) Penems 6-alquiliden heterotriciclil como inhibidores de la beta lactamasa
MX2009005912A (es) Derivados de etilamina-fenilo heterociclilo sustituidos, su preparacion y uso como medicamentos.

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]